Progressive multiple sclerosis: from pathogenic mechanisms to treatment

J Correale, MI Gaitán, MC Ysrraelit, MP Fiol - Brain, 2017‏ - academic.oup.com
During the past decades, better understanding of relapsing-remitting multiple sclerosis
disease mechanisms have led to the development of several disease-modifying therapies …

Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis

PL Foley, HM Vesterinen, BJ Laird, ES Sena, LA Colvin… - Pain®, 2013‏ - Elsevier
The prevalence, associations, and natural history of pain in multiple sclerosis (MS) are
poorly understood. The objective of this work was to study the prevalence of pain syndromes …

The multiple sclerosis care unit

P Soelberg Sorensen, G Giovannoni… - Multiple sclerosis …, 2019‏ - journals.sagepub.com
Treatment of multiple sclerosis (MS) has become increasingly multifaceted and comprises
not only a variety of disease-modifying drugs with different mechanism of action but also a …

A mechanism-based classification of pain in multiple sclerosis

A Truini, P Barbanti, C Pozzilli, G Cruccu - Journal of neurology, 2013‏ - Springer
Pharmacological treatment of pain in multiple sclerosis (MS) is challenging due to the many
underlying pathophysiological mechanisms. Few controlled trials show adequate pain …

Home-based balance training using the Wii balance board: a randomized, crossover pilot study in multiple sclerosis

L Prosperini, D Fortuna, C Giannì… - … and neural repair, 2013‏ - journals.sagepub.com
Objective. To evaluate the effectiveness of a home-based rehabilitation of balance using the
Nintendo Wii Balance Board System (WBBS) in patients affected by multiple sclerosis (MS) …

Rehabilitation interventions in multiple sclerosis: an overview

S Beer, F Khan, J Kesselring - Journal of neurology, 2012‏ - Springer
Multiple sclerosis is a complex, heterogeneous disease associated with long-term disability.
Despite the availability of advanced disease-modifying and symptomatic therapies that may …

Mitoxantrone for multiple sclerosis

FM Boneschi, L Vacchi, M Rovaris… - Cochrane Database …, 2013‏ - cochranelibrary.com
Mitoxantrone for multiple sclerosis - Martinelli Boneschi, F - 2013 | Cochrane Library Skip to
Content Cookies Our site uses cookies to improve your experience. You can find out more …

Exercise in multiple sclerosis--an integral component of disease management

A Döring, CF Pfueller, F Paul, J Dörr - Epma journal, 2012‏ - Springer
Multiple sclerosis (MS) is the most common chronic inflammatory disorder of the central
nervous system (CNS) in young adults. The disease causes a wide range of symptoms …

Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models

N Khan, MT Smith - Inflammopharmacology, 2014‏ - Springer
In patients with multiple sclerosis (MS), pain is a frequent and disabling symptom. The
prevalence is in the range 29–86% depending upon the assessment protocols utilised and …

Flavonoids, the compounds with anti-inflammatory and immunomodulatory properties, as promising tools in multiple sclerosis (MS) therapy: a systematic review of …

P Bayat, M Farshchi, M Yousefian, M Mahmoudi… - International …, 2021‏ - Elsevier
Multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), an animal
model of MS, are diseases resulting in neurological disabilities that are regarded as chronic …